Ingena's CEO

Dr Erin Evans, PhD, MBA, B App Sc. (Biotech) (Hons I) 

Erin is an experienced CEO, Board Chair and Director and start up founder. She is currently CEO of InGeNA, the national peak Industry body for genomics and precision medicine and previously led Life Sciences Queensland. She is an executive and entrepreneurial leader with a strong focus on strategic partnership and innovation spanning industries including biotech, digital technology, defence and higher education.   

She started her career in Biotechnology, completing her PhD at University of Queensland. She worked in the Pharma-Biotech industry in Australia and then in Europe and North America working with Abbott, Allergan, Genzyme (now Sanofi) and IQVIA leading global clinical development and quality.  

Erin is cofounder of a tech start-up and grew the team and launched the product globally securing venture capital and international partnerships.  

She is adjunct faculty at the Queensland University of Technology and in the Queensland Health Improvement Fellowship specialising in systems thinking and leading in complexity.  

Erin is the former Chair of Health Consumers Queensland where she partnered with the health system providing consumer advocacy and system improvement. She worked on the pandemic response and vaccine rollout with Queensland Health and diverse NGOs to enable a consumer-focused approach. She led the Queensland Genomics Advisory Board delivering projects to mainstream genomics providing health equity and access for all Queenslanders.  She is a founding member of the Queensland XR Hub Advisory Board.  

Erin has an MBA and is a graduate of Australian Institute of Company Directors and the Advisory Board Centre.